A bone-derived mixture of TGFβ-superfamily members forms a more mature vascular network than bFGF or TGF-β2 in vivo

Angiogenesis

Volumn 8, Issue 4, 2006, Pages 327-338

  Roedersheimer, Mark ^a,b   West, James ^a   Huffer, William ^a   Harral, Julie ^a   Benedict, James ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b Sulzer Biologics   (United States)

Author keywords

Angiogenesis; BMP; Bone derived mixture; Matrigel plug assay; TGF ; Therapeutic angiogenesis

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; BONE DERIVED GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN; CD31 ANTIGEN; SMOOTH MUSCLE ACTIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BIOACCUMULATION; BLOOD VESSEL; CAPILLARY; CARDIOVASCULAR SYSTEM; CELL ENCAPSULATION; CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; ERYTHROCYTE; FEMALE; GRANULATION TISSUE; IMPLANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE;

ACTINS; ANIMALS; CAPILLARIES; CELL LINE, TUMOR; EDEMA; ERYTHROCYTES; FEMALE; FEMUR; FIBROBLAST GROWTH FACTOR 2; HUMANS; MICE; MICE, INBRED C57BL; MULTIGENE FAMILY; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, NUDE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2;

ANIMALIA; BOVINAE;

EID: 33644596212     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-005-9022-9     Document Type: Article

References (49)

1. Annex BH, Simons M. Growth factor-induced angiogenesis in the heart: Protein therapy. Cardiovasc Res 2005; 65: 649-55.
2. Cao Y, Hong A, Schulten H, Post MJ. Update on therapeutic neovascularization. Cardiovasc Res 2005; 65: 639-48.
3. Lebrin F, Deckers M, Bertolino P, ten Dijke P. TGF-β Receptor function in the endothelium. Cardiovasc Res 2005; 65: 599-608.
4. Roethy W et al. A growth factor mixture that significantly enhances angiogenesis in vivo. JPET 2001; 299: 494-500.
5. Jain RK. Molecular regulation of vessel maturation. Nature Med 2003; 9(6): 685-93.
6. Carano RAD, Filvaroff EH Angiogenesis and bone repair. Drug Discovery Today 2003; 8(21): 980-9.
7. Deckers MM, van Bezooijen RL, van der Horst G et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived Vascular Endothelial Growth Factor-A. Endocrinology 2002; 143(4): 1545-53.
8. Marrony S, Bassilana F, Seuwen K, Keller H. Bone morphogenetic protein 2 induces placental growth factor in mesenchymal cells. Bone 2003; 33(3): 426-33.
9. Tokuda H, Hatakeyama D, Akamatsu S et al. Involvement of MAP kinases in TGF-beta-stimulated vascular endothelial growth factor synthesis in osteoblasts. Arch Biochem Biophys 2003; 415(1): 117-25.
10. Yeh LC, Lee JC Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells. Mol Cell Endocrinol 1999; 153(1-2): 113-24.
11. Fujimura K, Bessho K, Okubo Y et al. The effect of fibroblast growth factor-2 on the osteoinductive activity of recombinant human bone morphogenetic protein-2 in rat muscle. Arch Oral Biol 2002; 47(8): 577-84.
12. Nakamura Y, Tensho K, Nakaya H et al. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone 2005; 36(3): 399-407.
13. Kubota K, Iseki S, Kuroda S et al. Synergistic effect of fibroblast growth factor-4 in ectopic bone formation induced by bone morphogenetic protein-2. Bone 2002; 31(4): 465-71.
14. King KE, Iyemere VP, Weissberg PL et al. Kruppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and Transforming Growth Factor β1 in the regulation of vascular smooth muscle cell phenotype. J Biol Chem 2003; 278(13): 11661-9.
15. Kowanetz M, Valcourt U, Bergstrom R et al. Id2 and Id3 define the potency of cell proliferation and differentiation responses to Transforming Growth Factor β and bone morphogenetic protein. Mol Cell Biol 2004; 24(10): 4241-54.
16. Miyazono K and Miyazawa K. Id: A Target of BMP Signaling. Sci STKE 2002; 151: PE40.
17. Goumans M-J, Lebrin F, Valdimarsdottir G. Controlling the angiogenic switch: A balance between two distinct TGF-β receptor signaling pathways. Trends Cardiovascular Med 2003; 13: 301-7.
18. Yancopoulos GD, Davis S, Gale NW et al. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242-8.
19. Passaniti A, Taylor RM, Pili R et al. Methods in laboratory investigation: A simple quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 1992; 67(4): 519-28.
20. Ohashi K, Yokoyama T, Nakajima Y et al. Technical Bulletin #455: Methods for implantation of BD Matrigel matrix into mice and tissue fixation, http://www.bdbiosciences.com.
21. Isaji M, Miyata H, Ajisawa Y et al. Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo. Br J Pharmacol 1997; 122(6): 1061-6.
22. Murayama T, Tepper OM, Silver M et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 2002; 30(8): 967-72.
23. Langenfeld EM, Langenfeld J. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2004; 2(3): 141-9.
24. Huang SP, Wu MS, Shun CT et al. Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. J Biomed Sci 2004; 11(4): 517-27.
25. Maekawa H, Oike Y, Kanda S et al. Ephrin-B2 induces migration of endothelial cells through the phosphatidylinositol-3 kinase pathway and promotes angiogenesis in adult vasculature. Arterioscler Thromb Vasc Biol 2003; 23(11): 2008-14.
26. Silvestre JS, Tamarat R, Ebrahimian TG et al. Vascular Endothelial Growth Factor-B promotes in vivo angiogenesis. Circ Res 2003; 93(2): 114-23.
27. Kim HS, Shin HS, Kwak HJ et al. Betacellulin induces angiogenesis through activation of mitogen-activated protein kinase and phosphatidylinositol 3'kinase in endothelial cell. FASEB J 2003; 17(2): 318-20.
28. Salani D, Taraboletti G, Rosano L et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates angiogenesis in vivo. Am J Pathol 2000; 157(5): 1703-11.
29. Salcedo R, Ponce ML, Young HA et al. Human endothelial cells express CCR2 and respond to MCP-1: Direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000; 96(1): 34-40.
30. Salcedo R, Young HA, Ponce ML et al. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3 + endothelial cells. J Immunol 2001; 166(12): 7571-8.
31. Lee OH, Kim YM, Lee YM et al. Sphingosine 1-phosphate induces angiogenesis: Its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem Biophys Res Commun 1999; 264(3): 743-50.
32. Hartlapp I, Abe R, Saeed RW et al. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 2001; 15: 2215-24.
33. Al-Khaldi A et al. Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo. Gene Therapy 2003; 10: 621-9.
34. Bompais H, Chagraoui J, Canron X et al. Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood 2004; 103: 2577-84.
35. Jain RK Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 2005; 307(5706): 58-62.
36. Damien CJ, Grob D, Boden SD et al. Purified bovine bmp extract and collagen for spine arthrodesis - preclinical safety and efficacy. SPINE 2002; 27(16S): S50-8.
37. Sampath TK, Rashka KE, Doctor JS et al. Drosophila Transforming Growth Factor β superfamily proteins induce endochondral bone formation in mammals. Proc Natl Acad Sci 1993; 90: 6004-8.
38. Huffer WE, Lewis M, Barnes T, Benedict JJ. Strategies for tailoring bone and connective tissue regeneration using bone protein. In Davies JE (eds): Bone Engineering: An International Workshop. Toronto: University of Toronto Press 2001; 408-20.
39. Buschmann I, Heil M, Jost M, Schaper W. Influence of inflammatory cytokines on arteriogenesis. Microcirculation 2003; 10: 371-9.
40. Helisch A, Schaper W. Arteriogenesis: The development and growth of collateral arteries. Microcirculation 2003; 10: 83-97.
41. Sorescu GP, Sykes M, Weiss D et al. Bone morphogenetic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response. J Biol Chem 2003; 278(33): 31128-35.
42. Fajardo LF, Prionas SD, Kwan HH et al. Transforming Growth Factor β1 induces angiogenesis in vivo with a threshold pattern. Lab Invest 1996; 74: 600-8.
43. Bahamonde ME, Lyons KM. BMP3: To be of not to be a BMP. J Bone Joint Surg Am 2001; 83: 56-62.
44. Ramoshebi LN, Ripamonti U. Osteogenic protein-1, a bone morphogenetic protein, induces angiogenesis in the chick chorioallantoic membrane and synergizes with basic fibroblast growth factor and Transforming Growth Factor-β1. Anat Rec 2000; 259: 97-107.
45. Koike N, Fukumura D, Gralla O et al. Creation of long-lasting blood vessels. Nature 2004; 428: 138-9.
46. Hogan BL. Bone morphogenetic proteins in development. Curr Opin Genet Dev 1996; 6(4): 432-8.
47. Chen D, Zhao M, Harris SE, Mi Z. Signal transduction and biological functions of bone morphogenetic proteins. Front Biosci 2004; 9: 349-58.
48. Roelen BAJ, ten Dijke P. Controlling mesenchymal stem cell differentiation by TGFβ family members. J Orthop Sci 2003; 8: 740-8.
49. Sipe JB, Zhang J, Waits C et al. Localization of bone morphogenetic proteins (BMPs)-2, -4, and -6 within megakaryocytes and platelets. Bone 2004; 35(6): 1316-22.